TuHURA Biosciences, Inc. (HURA)
2.26
-0.09
(-3.83%)
USD |
NASDAQ |
May 29, 16:00
2.27
+0.01
(+0.44%)
After-Hours: 20:00
TuHURA Biosciences Shareholders Equity (Quarterly) : 23.19M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cardiff Oncology, Inc. | 34.71M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
| Savara, Inc. | 176.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.70M |
| Total Liabilities (Quarterly) | 6.515M |
| Debt to Equity Ratio | 0.0197 |
| Current Ratio | 1.151 |
| Net Debt Paydown Yield | -0.04% |